A pharmacokinetic analysis identified 86 drugs with substantial sex differences. Women given the same dose as men routinely had higher blood concentrations and/or longer elimination times. For drugs with higher pharmacokinetic exposure in w
A 2023 survey of U.S. obstetrics and gynecology residency program directors (99 of 145 responded) found that only 31.3% of programs had a menopause curriculum, and only 29.3% gave trainees dedicated time in a menopause clinic. 83 of the 99
CDC final 2024 data report that the suicide rate among males was nearly four times the rate among females. In 2023, the age-adjusted suicide rate was 22.7 deaths per 100,000 males versus 5.9 per 100,000 females, and males accounted for near
A JAMA analysis of U.S. medical marketing found that spending on direct-to-consumer prescription-drug advertising increased from $1.3 billion in 1997 to $6.0 billion in 2016, measured in 2016 dollars.
A 2019 survey of residents in family medicine, internal medicine, and obstetrics and gynecology at 20 U.S. programs found that only 6.8% (12 of 177) felt adequately prepared to manage women experiencing menopause. 20.3% said they had receiv
In 2024, the age-adjusted drug-overdose death rate was 32.2 per 100,000 for males and 14.1 per 100,000 for females. Both rates fell sharply from 2023, but the male rate remained more than twice the female rate.
The same JAMA analysis counted about 79,000 direct-to-consumer prescription-drug advertisements in 1997 and about 4.6 million in 2016. The 2016 total included roughly 663,000 television commercials.
A study in the New England Journal of Medicine checked postmenopausal women with hypothyroidism who were taking thyroid hormone (thyroxine) before and after they started estrogen, every six weeks for 48 weeks. In 7 of the 18 women on standa
In 2024, life expectancy at birth was 76.5 years for males and 81.4 years for females in the United States, a gap of 4.9 years.
A JAMA analysis estimated that total U.S. medical marketing spending on drugs, disease-awareness campaigns, health services, and laboratory testing increased from $17.7 billion in 1997 to $29.9 billion in 2016, measured in 2016 dollars.
